Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma

Eribulin mesylate is a novel, non-taxane, synthetic microtubule inhibitor showing antitumor activity in a wide range of tumors including soft tissue sarcomas (STS). Eribulin has been recently approved for the treatment of metastatic liposarcoma (LPS) patients previously treated with anthracyclines....

Descripción completa

Detalles Bibliográficos
Autores principales: De Vita, Alessandro, Miserocchi, Giacomo, Recine, Federica, Mercatali, Laura, Pieri, Federica, Medri, Laura, Bongiovanni, Alberto, Cavaliere, Davide, Liverani, Chiara, Spadazzi, Chiara, Amadori, Dino, Ibrahim, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273088/
https://www.ncbi.nlm.nih.gov/pubmed/27918490
http://dx.doi.org/10.3390/molecules21121662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273088/
https://www.ncbi.nlm.nih.gov/pubmed/27918490
http://dx.doi.org/10.3390/molecules21121662

Ejemplares similares